Last reviewed · How we verify

NCT04023734

A Targeted and Tailored Pharmacist Intervention to Improve Adherence to Antihypertensive Drugs Among Diabetes Patients

Completed NA Last updated 24 March 2020
What this trial tests

NA trial testing Reminders, habit-based strategies and/or involvement of family member in Diabetes Mellitus, Type 2 in 113 participants. Completed in 30 January 2020.

Timeline
16 August 2019
Primary endpoint
30 December 2019
30 January 2020

Quick facts

Lead sponsorUniversity of Groningen
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment113
Start date16 August 2019
Primary completion30 December 2019
Estimated completion30 January 2020
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

University of Groningen

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 2 or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to assess the effect of a targeted and tailored pharmacist intervention on medication adherence among diabetes patients non-adherent to antihypertensive drugs. The secondary objectives are to assess the effect of the intervention on blood pressure level and medication beliefs, and to evaluate the implementation and adoption of the intervention for pharmacists and patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effectiveness of a targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: A cluster randomised controlled trial.
    Alfian SD, van Boven JFM, Abdulah R, Sukandar H, et al · · 2021 · cited 31× · PMID 33085801 · DOI 10.1111/bcp.14610
  2. Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial.
    Alfian SD, Abdulah R, Denig P, van Boven JFM, et al · · 2020 · cited 7× · PMID 31911526 · DOI 10.1136/bmjopen-2019-034507
  3. Process Evaluation of Implementing a Pharmacist-Led Intervention to Improve Adherence to Antihypertensive Drugs Among Patients with Type 2 Diabetes in Indonesian Community Health Centers.
    Alfian SD, van Boven JFM, Iskandarsyah A, Abdulah R, et al · · 2021 · cited 4× · PMID 34025419 · DOI 10.3389/fphar.2021.652018

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

Other University of Groningen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing